6.
Schwallie P
. Experience with Depo-provera as an injectable contraceptive. J Reprod Med. 1974; 13(3):113-7.
View
7.
Ferro J, Canhao P, Stam J, Bousser M, Barinagarrementeria F
. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke. 2004; 35(3):664-70.
DOI: 10.1161/01.STR.0000117571.76197.26.
View
8.
Luo Y, Tian X, Wang X
. Diagnosis and Treatment of Cerebral Venous Thrombosis: A Review. Front Aging Neurosci. 2018; 10:2.
PMC: 5797620.
DOI: 10.3389/fnagi.2018.00002.
View
9.
Pai N, Ghosh K, Shetty S
. Hereditary thrombophilia in cerebral venous thrombosis: a study from India. Blood Coagul Fibrinolysis. 2013; 24(5):540-3.
DOI: 10.1097/MBC.0b013e32835fad1e.
View
10.
Devasagayam S, Wyatt B, Leyden J, Kleinig T
. Cerebral Venous Sinus Thrombosis Incidence Is Higher Than Previously Thought: A Retrospective Population-Based Study. Stroke. 2016; 47(9):2180-2.
DOI: 10.1161/STROKEAHA.116.013617.
View
11.
Ghoneim A, Straiton J, Pollard C, MacDonald K, Jampana R
. Imaging of cerebral venous thrombosis. Clin Radiol. 2020; 75(4):254-264.
DOI: 10.1016/j.crad.2019.12.009.
View
12.
Ferro J, Dentali F, Coutinho J, Kobayashi A, Caria J, Desch M
. Rationale, design, and protocol of a randomized controlled trial of the safety and efficacy of dabigatran etexilate versus dose-adjusted warfarin in patients with cerebral venous thrombosis. Int J Stroke. 2018; 13(7):766-770.
DOI: 10.1177/1747493018778125.
View
13.
Berti C, Fekete K, Dullemeijer C, Trovato M, Souverein O, Cavelaars A
. Folate intake and markers of folate status in women of reproductive age, pregnant and lactating women: a meta-analysis. J Nutr Metab. 2012; 2012:470656.
PMC: 3449134.
DOI: 10.1155/2012/470656.
View
14.
Patil V, Choraria K, Desai N, Agrawal S
. Clinical profile and outcome of cerebral venous sinus thrombosis at tertiary care center. J Neurosci Rural Pract. 2014; 5(3):218-24.
PMC: 4078604.
DOI: 10.4103/0976-3147.133559.
View
15.
Iyer R, Tcr R, Akhtar S, Muthukalathi K, Kumar P, Muthukumar K
. Is it safe to treat cerebral venous thrombosis with oral rivaroxaban without heparin? A preliminary study from 20 patients. Clin Neurol Neurosurg. 2018; 175:108-111.
DOI: 10.1016/j.clineuro.2018.10.015.
View
16.
Dhadke V, Dhadke S, Kulkarni A
. Clinical Profile of Cerebral Venous Sinus Thrombosis. J Assoc Physicians India. 2020; 68(3):33-35.
View
17.
Feher G, Illes Z, Komoly S, Hargroves D
. Novel oral anticoagulants in the treatment of cerebral venous thrombosis. Int Angiol. 2015; 35(4):365-8.
View
18.
Miranda B, Aaron S, Arauz A, Barinagarrementeria F, Borhani-Haghighi A, Carvalho M
. The benefit of EXtending oral antiCOAgulation treatment (EXCOA) after acute cerebral vein thrombosis (CVT): EXCOA-CVT cluster randomized trial protocol. Int J Stroke. 2018; 13(7):771-774.
DOI: 10.1177/1747493018778137.
View
19.
Sasidharan P
. Cerebral vein thrombosis misdiagnosed and mismanaged. Thrombosis. 2012; 2012:210676.
PMC: 3337512.
DOI: 10.1155/2012/210676.
View
20.
Hitosugi M, KITAMURA O, Takatsu A, Watanabe K, Kan S
. [A case of dural sinus thrombosis during the medication of medroxyprogesterone acetate]. Nihon Hoigaku Zasshi. 1998; 51(6):452-6.
View